Pulmonary artery pressures and valvular lesions in patients taking diet suppressants

Cardiovascular Reviews and Reports

Volumn 19, Issue 4, 1998, Pages 13-16

  Fisher, Edward A ^a   Ruden, Ronald ^b,c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PHENTERMINE;

ADULT; AGED; ARTICLE; DOPPLER ECHOCARDIOGRAPHY; DRUG WITHDRAWAL; FEMALE; HEART VALVE; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

EID: 0031967393     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Weintraub M. Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study Clin Pharmacol Ther. 1992;51:581-646.
2. Abenheim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609-616.
3. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-588.
4. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657-662.
5. Weyman AE. Principles and Practice of Echocardiography, 2nd Ed. Philadelphia: Lea & Febiger; 1994:879.
6. McGoon MD, Fuster V, Freeman WK, et al. Pulmonary hypertension. In: Giuliani ER, Fuster V, Gersh BJ, et al. (eds). Cardiology: Fundamentals and practice, 2nd Ed. St. Louis, MO: Mosby-Year Book; 1991:2051-2068.
7. Fisher EA, Goldman ME. Simple, rapid method for quantification of tricuspid regurgitation by two-dimensional echocardiography. Am J Cardiol 1989;63:1375-1378.
8. Choong CY, Abascal VM, Weyman A, et al. Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography. Am Heart J. 1989;117:636-642.
9. Klein AL, Burstow DJ, Tajik AJ, et al. Age-related prevalence of valvular regurgitation in normal subjects: A comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr. 1990;3:54-63.
10. Robiolio PA, Rigolin VH, Wilson JS, et al. Carcinoid heart disease: Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiograph. Circulation. 1995;92:790-795.
11. Redfield MM, Nicholson WJ, Edwards WD, et al. Valve disease associated with ergot alkaloid use: Echocardiographic and pathologic correlations. Ann Intern Med. 1992;117:50-52.
12. Morita T, Mehendale HM. Effects of chlorphentermine and phentermine on the pulmonary disposition of 5-hydroxytryptamine in the rat in vivo. Am Rev Respir Dis. 1983;127:747-750.